CTRI/2023/12/060828招募中Unknown
Improving Survival in Childhood Acute Lymphoblastic Leukemia in India (ISCALL): ICiCLe Implementation Study - ISCA
Cancer Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Newly diagnosed pediatric acute lymphoblastic leukemia (ALL).
排除标准
- •1. Relapsed or refractory ALL.
- •2. Mixed-phenotype acute leukemia.
研究者
相似试验
Unknown
2 期
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in ChildrenChildAcute Lymphoblastic LeukemiaNCT02339350The Korean Society of Pediatric Hematology Oncology110
已完成
不适用
Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1Acute Lymphoblastic LeukemiaJPRN-UMIN000003375Tokyo Children's Cancer Study Group400
招募中
不适用
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALLAcute Lymphoblastic LeukemiaNCT05811845IRCCS Burlo Garofolo250
已完成
3 期
Treatment of Acute Lymphoblastic Leukemia in ChildrenAcute Lymphoblastic LeukemiaNCT00165178Dana-Farber Cancer Institute498
进行中（未招募）
1 期
Therapy of the Young Adult Acute Lymphoblastic Leukemia (ALL): treatment intensification of the pediatric protocol AIEOP LLA-2000 - GIMEMA LAL 1308Acute Lymphoblastic Leukemia (ALL)MedDRA version: 9.1Level: LLTClassification code 10000844EUCTR2009-016075-30-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL`ADULTO30